RAFA

Rafarma Pharmaceuticals, Inc. RAFA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RAFA LIFD LUFFF MVMDF ANTCF OWPC IVIXF CNGGF LVRLF BSPK
6M -56.67 % -32.50 % 23.53 % -46.61 % -69.09 % -19.65 % 0.00 % -50.00 % -73.56 % 204.65 %
YTD -61.00 % -44.90 % -80.36 % -51.54 % -88.96 % -23.65 % -83.23 % -58.33 % -40.50 % 105.48 %
1Y -41.79 % -61.43 % -89.50 % -45.69 % -84.82 % -34.29 % -89.21 % 0.00 % -52.40 % 20.06 %
3Y -89.20 % -92.06 % -99.24 % -66.40 % -73.85 % -84.51 % -94.01 % -97.16 % -86.00 % -51.52 %
5Y -97.80 % -79.55 % -99.81 % -86.92 % -97.95 % -87.22 % -95.90 % -98.99 % -84.13 % 3 521 016.43 %
10Y 387.50 % -78.40 % -99.81 % -74.34 % -97.95 % -99.10 % -90.73 % -98.99 % -98.02 % 2 600.00 %
From the beginning -97.11 % -92.80 % -100.00 % -74.34 % -97.95 % -99.10 % -99.33 % -98.99 % -98.02 % -64.00 %

Dividend